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Abstract—Herpes simplex virus type 1 is a highly contagious worldwide prevalent infection, which, once it
enters the organism, persists during its whole lifetime. According to World Health Organization estimates,
about 3.7 billion people under the age of 50 years (90% of the human population) are infected with by HSV-1
worldwide. The important role played by ribonucleases (RNases) in protection of the cell and whole organism
from viruses has been confirmed by a considerable body of data that allow considering RNases not only as
immune system components, but also as a basis for development of the new antiviral drugs. The purpose of
the present work was to demonstrate the antiviral activity of the RNase from Bacillus pumilus (binase) toward
HSV-1 at the cell entrance and reproduction stages. Virus treatment with binase in the concentration of
100 μg/mL for 60 min reduced virus replication in the bovine kidney epithelial cell culture MDBK by 100 times
compared with untreated virus. Development of cytopathic effects produced by untreated virus in the cells
grown on the medium with binase was retarded by 7 h compared with the growth of virus-infected cells on the
medium without binase. It may be suggested that HSV-1 treatment with RNases reduces its ability to enter
the cell; antiviral action of RNases toward the intracellular virus is realized at the initial stage of virus repro-
duction.




The importance of herpes virus infection as a criti-
cal medical and social problem increases every year
due to its ubiquitous distribution, persistence in the
organism in latent form, high frequency of reactivation,
and. finally, carcinogenicity of certain viruses [1, 2]. The
family Herpesviridae includes more than 80 represen-
tatives, 8 antigenic serotypes among them being
pathogenic for human beings. Antibodies against
these viruses are detected in 80–90% of adult people
[3]. Herpes viruses may exist in the organism in three
main forms, namely, in extracellular and intracellular
forms and as a part of immune complexes, which
largely determines their sensitivity to different antivi-
rus chemotherapeutic agents, immunomodulators,
and symptom-relieving drugs [4]. Although incorpo-
ration of panavir and acyclovir in the complex therapy
contributes to a more pronounced clinical effect, in
most cases, occasional use of virostatics does not pro-
tect from subsequent remissions [4]. In this view, the
search for the new antiviral agents is a critical task.
That a role is played by RNases in the protection of
cells and the whole organism from viruses is supported
by a considerable body of data, which allow consider-
ing RNases not solely as components of the immune
system, but also as the basis for development of the
new antiviral drugs [5]. Our previous studies have
shown that secreted RNase from Bacillus pumilus
(binase) inhibits reproduction of the serotype I reovi-
rus [6] and appears to be a promising agent to serve
basis for the development of the drug against pan-
demic influenza virus [7, 8].
In view of the above, the aim of the present work
was to demonstrate the antiviral activity of bacillar
RNase (binase) toward herpes simplex virus HSV-1 at
the cell entry and reproduction stages.
MATERIALS AND METHODS
Virus and cell culture. The work was carried out
using the attenuated herpes simplex virus type 1 strain
TK-A(VIEV)V-2 (HSV-1) (from the collection of the
Kovalenko All-Russia Research Institute of Experi-
mental Veterinary, Moscow) and the passaged line of
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